Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1144 (LINC01144)

Target
LINC01144
Molecular classification
Long noncoding RNA (lncRNA), Non-protein coding RNA, Intergenic lncRNA
01

Overview

Long intergenic non-protein coding RNA 1144 (LINC01144) is a long noncoding RNA (lncRNA) that is not translated into protein but plays regulatory roles in gene expression. LINC01144 is upregulated in colorectal cancer tissues and cell lines and is associated with tumor progression. It functions mechanistically as a competing endogenous RNA (ceRNA), sequestering microRNA-331 (miR-331), resulting in increased levels of HER2 (a recognized oncogenic receptor tyrosine kinase), as well as heightened Akt and ERK1/2 signaling, thus promoting proliferation and invasion of colorectal cancer cells. Silencing LINC01144 suppresses proliferation, reduces invasion, and increases apoptosis in colorectal cancer cell models. Its apparent disease relevance is so far limited primarily to colorectal cancer, with evidence supporting its role as a biomarker and possible therapeutic target in this malignancy, but there are no known drugs targeting LINC01144 or established clinical safety concerns associated with its modulation.

Other names
TCONS_00000513LINC01144long intergenic noncoding RNA 1144
02

Biological functions

Regulation of cell proliferationRegulation of cell invasionRegulation of apoptosisCompeting endogenous RNA (ceRNA) activity (sponging microRNAs)
03

Disease associations

Cancer (specifically implicated in colorectal cancer)
04

Biomarkers

Upregulation in colorectal cancer (potential prognostic biomarker)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1144 (LINC01144).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1144 (LINC01144).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call